Showing results (111-120 of 185) with videos related to

Sort By:
Pageof 19
Cancers|March 28, 2024
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1Ana Dillen, Indy Bui, Megan Jung, et al.
Nitric Oxide : Biology and Chemistry|February 22, 2015
Repeated sub-optimal photodynamic treatments with pheophorbide a induce an epithelial mesenchymal transition in prostate cancer cells via nitric oxideEmilia Della Pietra, Francesca Simonella, Benjamin Bonavida, et al.
Advances in Cancer Research|August 26, 2004
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosisGolaun Odabaei, Devasis Chatterjee, Ali R Jazirehi, et al.
Molecular Cancer Therapeutics|November 18, 2003
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosisAli R Jazirehi, Xiao-Hu Gan, Sven De Vos, et al.
Oncogene|August 17, 2005
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosisMario I Vega, Sara Huerta-Yepez, Ali R Jazirehi, et al.
Cytokine & Growth Factor Reviews|January 20, 2026
TGF-β-YY1 signaling as a key driver of immune evasion in pancreatic cancer: Therapeutic implicationsMai P Ho, Megan Jung, William Ung, et al.
Current Opinion in Hematology|June 10, 2008
NF-kappaB in the pathogenesis and treatment of multiple myelomaZhi-Wei Li, Haiming Chen, Richard A Campbell, et al.
Cancer Research|December 17, 2010
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interactionAli R Jazirehi, Stavroula Baritaki, Richard C Koya, et al.
International Journal of Oncology|April 2, 2011
The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosisStavroula Baritaki, Loredana Militello, Graziella Malaponte, et al.
Leukemia & Lymphoma|December 8, 2010
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cellsMario I Vega, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Pageof 19